|
Volumn 21, Issue 7, 2010, Pages 383-385
|
Clinical implications of the BARI 2D and COURAGE trials: Overview
|
Author keywords
angioplasty; bypass surgery; coronary artery disease; diabetes mellitus; myocardial infarction; revascularization
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
ANGIOCARDIOGRAPHY;
ANGIOPLASTY;
ATHEROSCLEROTIC PLAQUE;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
CORONARY ARTERY RECANALIZATION;
HEART INFARCTION;
HUMAN;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
REVIEW;
STROKE;
ANGIOPLASTY, BALLOON, CORONARY;
CARDIOVASCULAR AGENTS;
CASE MANAGEMENT;
CLINICAL TRIALS AS TOPIC;
CORONARY ANGIOGRAPHY;
CORONARY ARTERY BYPASS;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS, TYPE 2;
GUIDELINE ADHERENCE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
INTENSIVE CARE;
MORTALITY;
MULTICENTER STUDIES AS TOPIC;
MYOCARDIAL INFARCTION;
PRACTICE GUIDELINES AS TOPIC;
RISK ASSESSMENT;
STROKE;
TREATMENT OUTCOME;
|
EID: 78049282758
PISSN: 09546928
EISSN: None
Source Type: Journal
DOI: 10.1097/MCA.0b013e32833d014a Document Type: Review |
Times cited : (5)
|
References (4)
|